Showing 3161-3170 of 5257 results for "".
- Study: This Is When to Use Adjuvant Therapy in Patients with Early Stage 3A Melanomahttps://practicaldermatology.com/news/study-this-is-when-to-use-adjuvant-therapy-in-patients-with-early-stage-3a-melanoma/2461313/
- Online Extra: Let’s Talk About Truncal Acnehttps://practicaldermatology.com/news/online-extra-lets-talk-about-truncal-acne/2461304/While often trivialized as a cosmetic skin disease, acne is in fact an inflammatory skin condition with a complex pathogenesis associated with a significant physical and psychological burden. Approximately 50% of people with facial acne also have truncal acne manifesting on the back, shoulders, a
- Tremfya Safe, Effective Across Broad Patient Subpopulations Through 5 Years: Analysishttps://practicaldermatology.com/news/tremfya-safe-effective-across-broad-patient-subpopulations-through-five-years-analysis/2461130/Tremfya® (guselkumab) from the Janssen Pharmaceutical Companies of Johnson & Johnson can provide a consistent, high degree of durable skin clearance through 5 years in a majority of adult patients across broad subpopulations with moderate to severe plaque psoriasis (PsO), based on an
- Differin Doubles Down on Retinoid Education Week with New Campaign Launchhttps://practicaldermatology.com/news/differin-doubles-down-on-retinoid-education-week-with-new-campaign-launch/2461100/Differin Gel is launching a digital and audio marketing campaign that will culminate in a strategic partnership with Acast Creative and the
- Third Harmonic Bio Launches with an Eye on Chronic Urticariahttps://practicaldermatology.com/news/third-harmonic-bio-launches-with-an-eye-on-chronic-urticaria/2461078/Third Harmonic Bio is launching with the close of a Series B financing campaign. With total capital to date of $155 million, the company plans to fund development of its lead candidate, THB001, through the next phase of human studies for the initial indication of chronic urticaria. 
- The National Eczema Association and Pediatric Dermatology Research Alliance Receive Collaborative Engagement Award from PCORIhttps://practicaldermatology.com/news/the-national-eczema-association-and-pediatric-dermatology-research-alliance-receive-collaborative-engagement-award-from-pcori/2461041/The
- The Proactiv Company Rebrands to Alchemee, Expands Skincare Offeringshttps://practicaldermatology.com/news/the-proactiv-company-rebrands-to-alchemee-expands-skincare-offerings/2460998/The Proactiv Company is rebranding and repositioning under the new name Alchemee. Alchemee will cater to a multitude of skin concerns, and focus not only on consumers' needs, but on meeting them where they are along their journey through both innovation and an omni-channe
- Novel Lyme Vaccine Shows Promise in Early Researchhttps://practicaldermatology.com/news/novel-lyme-vaccine-shows-promise-in-early-research/2460994/Yale University researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme disease and may also combat other tick-borne diseases, they report in the journal Science Translational Medicine. Instead of trig
- CeraVe Research Highlights the Impact of UV Exposure on the Skin Barrier and the Benefits of Ceramideshttps://practicaldermatology.com/news/cerave-research-highlights-the-impact-of-uv-exposure-on-the-skin-barrier-and-the-benefits-of-ceramides/2460859/A skincare regimen that includes a moisturizer and sunscreen formulated with ceramides can help protect against ultraviolet(UV)-induced skin barrier damage and improve skin barrier health overall, according to new research in the Journal of Drugs in Dermatology. The clin
- Meet PDO Max's New Executive Hireshttps://practicaldermatology.com/news/meet-pdo-maxs-new-executive-hires/2460810/Dina BenDavid is the new Director of Training and Clinical Development at PDO Max. BenDavid is a board-certified nurse practitioner, holds both a Master's and Doctoral degrees, and is a professor of nursing and clinical trainer in medical aesthetics. She is founder and owner of